Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mylan
Pharma
Viatris clears legal hurdle on road to potential Wegovy generic
Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesity.
Fraiser Kansteiner
Jul 24, 2025 10:42am
Viatris settles opioid claims, agreeing to pay up to $335M
Apr 7, 2025 10:48am
FDA warning letter reveals production errors at Viatris plant
Jan 6, 2025 4:20pm
Novo settles with Mylan over potential Ozempic generic
Oct 7, 2024 9:18am
Viatris, former president cleared in DOJ price-fixing probe
Jul 2, 2024 9:40am
Viatris official Rayapureddy cleared of insider trading charges
Jan 30, 2024 8:30am
